Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses

被引:0
|
作者
Yachida, Junko [1 ,2 ]
Fujihara, Kazuya [1 ]
Yamada, Mayuko Harada [1 ]
Kobayashi, Ayako [1 ,2 ]
Khin, Lay Mon [1 ]
Takizawa, Hiroki [1 ]
Yamamoto, Masahiko [1 ]
Kitazawa, Masaru [1 ]
Matsubayashi, Yasuhiro [1 ]
Yamada, Takaho [1 ]
Kodama, Satoru [1 ]
Sone, Hirohito [1 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan
[2] Niigata Coll Nursing, Joetsu, Japan
来源
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 12期
基金
日本学术振兴会;
关键词
cardiovascular disease; coronary artery disease; glucose abnormalities; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; STATIN-TREATED PATIENTS; APOLIPOPROTEIN-A-I; HEART-DISEASE; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; INSULIN-RESISTANCE; TOLERANCE STATUS; LDL CHOLESTEROL; MORTALITY; JAPAN;
D O I
10.1111/dom.15956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate the association between low-density lipoprotein-cholesterol (LDL-C) levels and coronary artery disease (CAD) incidence based on combining high-density lipoprotein-cholesterol (HDL-C) levels and glucose status. Materials and Methods: In this retrospective cohort study, we used data from a nationwide claims database (1,524,289 individuals without a history of CAD or familial hypercholesterolaemia; 2008-2019). Cox proportional hazards modelling identified the risk of incident CAD by a novel combination of four HDL-C levels, seven LDL-C levels and glucose status. Results: During the follow-up period (mean: 5.5 years), 8301 (0.99/1000 person-years) events occurred. The risk of CAD increased from lower LDL-C levels accompanied by lower HDL-C levels regardless of the glucose status. Using the most favourable levels of HDL-C and LDL-C (i.e. 60-99 mg/dL and <80 mg/dL, respectively) as references, the hazard ratios (95% confidence interval) for the group with HDL-C levels <40 mg/dL and LDL-C levels <80 mg/dL were 2.74 (1.47-5.11), 2.52 (1.30-4.91) and 2.85 (1.68-4.84) for normoglycaemia, borderline glycaemia and diabetes, respectively. Comparison of the most favourable levels of HDL-C and LDL-C with their least favourable levels (i.e. <40 mg/dL and 180-199 mg/dL, respectively) revealed that the risk of new-onset CAD exhibited a 19-, nine- and seven-fold increase in individuals with normoglycaemia, borderline glycaemia and diabetes, respectively. Conclusions: To prevent CAD, LDL-C levels should be strictly controlled in patients with low HDL-C levels regardless of glucose tolerance. Individualized treatment, which involves setting target LDL-C levels based on glucose tolerance and HDL-C values, is required.
引用
收藏
页码:5845 / 5856
页数:12
相关论文
共 50 条
  • [1] Management of Low Levels of High-Density Lipoprotein-Cholesterol
    Khera, Amit V.
    Plutzky, Jorge
    CIRCULATION, 2013, 128 (01) : 72 - 78
  • [2] Role of the Low-Density Lipoprotein-Cholesterol/ High-Density Lipoprotein-Cholesterol Ratio in Predicting Serial Changes in the Lipid Component of Coronary Plaque
    Kawakami, Ryo
    Matsumoto, Ichiro
    Shiomi, Motoi
    Kurozumi, Mizuki
    Miyake, Yuichi
    Ishizawa, Makoto
    Ishikawa, Kaori
    Murakami, Kazushi
    Noma, Takahisa
    Takagi, Yuichiro
    Nishimoto, Naoki
    Minamino, Tetsuo
    CIRCULATION JOURNAL, 2017, 81 (10) : 1439 - +
  • [3] HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS IN JAPAN
    UESHIMA, H
    IIDA, M
    SHIMAMOTO, T
    KONISHI, M
    TANIGAKI, M
    NAKANISHI, N
    TAKAYAMA, Y
    OZAWA, H
    KOJIMA, S
    KOMACHI, Y
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (14): : 1985 - 1987
  • [4] HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL IN DIABETICS
    STANTON, K
    MASSEREI, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1979, 9 (01): : 109 - 110
  • [5] HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL MEASUREMENT
    HOWANITZ, JH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (06): : 885 - 885
  • [6] Circadian Rhythm of Subspecies of Low-Density Lipoprotein-Cholesterol and High-Density Lipoprotein-Cholesterol in Healthy Subjects and Patients with Type 2 Diabetes
    Hayashi, Toshiyuki
    Ai, Masumi
    Goto, Satoshi
    Nakamura, Marie
    Nagaike, Hiroe
    Suzuki, Risa
    Abe, Yasuko
    Ohta, Motoko
    Ito, Yasuki
    Hirano, Tsutomu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (01) : 3 - 14
  • [7] ZINC LOWERS HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS
    HOOPER, PL
    VISCONTI, L
    GARRY, PJ
    JOHNSON, GE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (17): : 1960 - 1961
  • [8] Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men
    Zhang, B
    Bai, H
    Liu, R
    Kumagai, K
    Itabe, H
    Takano, T
    Saku, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (04): : 423 - 429
  • [9] Low-Density Lipoprotein-Cholesterol/High-Density Lipoprotein-Cholesterol Ratio Predicts Lipid-Rich Coronary Plaque in Patients With Coronary Artery Disease - Integrated-Backscatter Intravascular Ultrasound Study
    Kimura, Takumi
    Itoh, Tomonori
    Fusazaki, Tetsuya
    Matsui, Hiroki
    Sugawara, Shoma
    Ogino, Yoshinobu
    Endo, Hiroshi
    Kobayashi, Ken
    Nakamura, Motoyuki
    CIRCULATION JOURNAL, 2010, 74 (07) : 1392 - 1398
  • [10] Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio
    Satoshi Okumura
    Masaki Sakakibara
    Ryo Hayashida
    Yasushi Jinno
    Akihito Tanaka
    Koji Okada
    Mutsuharu Hayashi
    Hideki Ishii
    Toyoaki Murohara
    Heart and Vessels, 2014, 29 : 7 - 14